subject be currently treat with a stable dose of at least 1 aed for the 4 week prior to the screening visit visit 1 and throughout the duration of the treatment period with or without additional concurrent vagus nerve stimulation vns or other neurostimulation treatment the vns must have be in place for at least 12 month with constant setting for at least 3 month and the battery life of unit anticipate to extend for the duration of study prior to the screening visit and throughout the duration of the study 